Cancer Crosslinks 2025 on how innovations in basic research, translational research and technology can improve cancer patients’ lives – Oslo Cancer Cluster
Oslo Cancer Cluster shared a post on LinkedIn:
“Cancer Crosslinks 2025 put a spotlight on how innovations in basic research, translational research and technology can improve cancer patients’ lives, last Thursday at Oslo Cancer Cluster.
We are thrilled so many chose to participate in the conference to learn more about the latest in cancer research and engage in stimulating conversations during the networking breaks.
Thank you to speakers Vivek Subbiah, Ruth Plummer, Magnus Essand, Inge Marie Svane, Ingrid Stenstadvold Ross, Joel Hedlund and moderators Åsmund Flobak, Else Marit Inderberg, Eli Sihn Samdal Steinskog, Hanne Hamre for contributing to an inspiring educational programme.
A special thank you to the sponsors Bristol Myers Squibb and Kite Pharma (A Gilead Company) for making this year’s edition possible.
View pictures from the day here.
Get in touch with the Oslo Cancer Cluster organising team, if you have any questions or feedback: Charlotte Homme, Marine Jeanmougin, Dave Tippett, Jutta Heix.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023